Alkermes ( ($ALKS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Alkermes’ stock movement is driven by positive developments, including Deutsche Bank’s initiation of coverage with a Buy rating, thanks to growth prospects and advancements in their product pipeline, notably the Orexin program with the ALKS 2680 candidate. The company’s strategic preparations for post-credit termination flexibility have further strengthened its outlook. Analysts remain optimistic ahead of the earnings report, expecting the stock to maintain its upward trajectory. The stock holds a consensus Strong Buy rating, and various analysts have increased their price targets, indicating anticipated continued growth.
More about Alkermes
YTD Price Performance: 8.63%
Average Trading Volume: 1,511,817
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $5.11B
For further insights into ALKS stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.
